CCMH
LFCR icon

Cornerstone Capital Management Holdings’s Lifecore Biomedical LFCR Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-300
Closed -$3K – 1277
2017
Q3 		$3K Buy
+300
New +$3.96K ﹤0.01% 1252
2014
Q1 		– Sell
-1,600
Closed -$19K – 1366
2013
Q4 		$19K Buy
+1,600
New +$19.1K ﹤0.01% 1208

Other funds holding LFCR

NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Cornerstone Capital Management Holdings's LFCR Position: Q4 2017 in Review

Cornerstone Capital Management Holdings sold out of Lifecore Biomedical (LFCR) in Q4 2017, closing a stake of 300 shares — an estimated $3K sold.

Cornerstone Capital Management Holdings first reported a position in LFCR in Q4 2013 and held it in 2 quarters. The position peaked at $19K in Q4 2013. 91 funds tracked by Wall St. Rank hold LFCR as of Q4 2017.

  • Cornerstone Capital Management Holdings reported no remaining Lifecore Biomedical position as of Q4 2017 after selling out during the quarter.
  • Cornerstone Capital Management Holdings sold 300 Lifecore Biomedical shares in Q4 2017, an estimated $3K.
  • Cornerstone Capital Management Holdings first reported a position in Lifecore Biomedical in Q4 2013 and held it in 2 quarters.
  • Cornerstone Capital Management Holdings's Lifecore Biomedical position peaked at $19K in Q4 2013.
  • 91 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.